IL6 and renal cell carcinoma: G3BP1 contributes to the proliferation, migration and invasion of renal cell carcinoma (RCC), and knockdown of G3BP1 blocks the IL-6/STAT3 signaling and reduces the metastatic ability of RCC (126) (Figure 3).